Clinical Trials Browser

Phase 2 × Recruiting × Lymphomatoid Papulosis × Clear all

NCT03587844 2025-11-03

Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

Phase 2 Recruiting

Mycosis Fungoides, Sezary Syndrome, Lymphomatoid Papulosis